NEW YORK (GenomeWeb) – Fluxion Biosciences announced today that it is collaborating with the University of Texas Health Science Center at Houston, or UTHealth, to develop novel liquid biopsy approaches to diagnose, monitor, and treat cancer patients.

The collaboration focuses around work being done in the laboratory of Roberto Amato, a professor and director of oncology at UTHealth Medical School. His lab is utilizing Fluxion's IsoFlux System to isolate, recover, and analyze rare circulating tumor cells (CTCs) at the molecular level.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.